日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative Magnetic Resonance Spectroscopy and T2 Mapping for Evaluating Knee Subchondral Bone and Cartilage Changes in Chronic Kidney Disease

定量磁共振波谱和T2映射技术在慢性肾脏病膝关节软骨下骨和软骨变化评估中的应用

Chiang, Shih-Wei; Hsu, Yu-Juei; Peng, Yi-Jen; Hsu, Yi-Chih; Yeh, Skye Hsin-Hsien; Chou, Yu-Ching; Lee, Herng-Sheng; Liu, Ying-Chun; Wang, Chao-Ying; Huang, Guo-Shu

Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients

组胺 N-甲基转移酶 (HNMT) 作为预测乳腺癌患者对抗 HER2 药物治疗适应性的潜在辅助生物标志物

Tzu-Chun Cheng #, Mien-Chie Hung #, Lu-Hai Wang #, Shih-Hsin Tu #, Chih-Hsiung Wu, Yun Yen, Chi-Long Chen, Jacqueline Whang-Peng, Wen-Jui Lee, You-Cheng Liao, Yu-Ching Lee, Min-Hsiung Pan, Hui-Kuan Lin, Huey-En Tzeng, Peixuan Guo, Cheng-Ying Chu, Li-Ching Chen, Yuan-Soon Ho7

Comparison of regional and general anesthesia for retrograde intrarenal surgery: a systematic review and meta-analysis

区域麻醉与全身麻醉在逆行性肾内手术中的比较:系统评价和荟萃分析

Ho, Yen; Wen, Yu-Ching; Lee, Liang-Ming; Lin, Ke-Hsun; Hsiao, Chi-Hao; Syu, Syuan-Hao; Lai, Benjamin Chung-Howe; Chung, Cho-Hsing; Lin, Yung-Wei

Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4

针对乳腺癌肿瘤标志物 nectin-4 的单链可变片段抗体的制备及表征

Ching-Hsuan Liu #, Sy-Jye Leu #, Chi-Hsin Lee, Cheng-Yuan Lin, Wei-Chu Wang, Bor-Yu Tsai, Yu-Ching Lee, Chi-Long Chen, Yi-Yuan Yang, Liang-Tzung Lin

The Blockade of Mitogen-Activated Protein Kinase 14 Activation by Marine Natural Product Crassolide Triggers ICD in Tumor Cells and Stimulates Anti-Tumor Immunity

海洋天然产物Crassolide通过阻断丝裂原活化蛋白激酶14的活化,触发肿瘤细胞的免疫原性细胞死亡并刺激抗肿瘤免疫。

Keng-Chang Tsai ,Chia-Sheng Chen ,Jui-Hsin Su ,Yu-Ching Lee ,Yu-Hwei Tseng ,Wen-Chi Wei

Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment

抗红细胞生成素肝细胞受体A2型抗体在胰腺癌治疗中的有效性

Fu-Ling Chang, Keng-Chang Tsai, Tsai-Yu Lin, Chen-Wei Chiang, Shiow-Lin Pan, Yu-Ching Lee

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors

对于接受一线贝伐珠单抗联合第一/二代EGFR酪氨酸激酶抑制剂治疗的晚期表皮生长因子受体突变肺腺癌患者,序贯治疗方案

Hsu, Ping-Chih; Huang, Chun-Yao; Lin, Yu-Ching; Lee, Suey-Haur; Chiu, Li-Chung; Wu, Chiao-En; Kuo, Scott Chih-Hsi; Ju, Jia-Shiuan; Huang, Allen Chung-Cheng; Ko, Ho-Wen; Wang, Chin-Chou; Yang, Cheng-Ta

Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer

阻断EphA4功能的单链片段抗体作为胃癌治疗药物

Chen-Wei Chiang, Yun-Shih Lin, Fu-Ling Chang, Tsai-Yu Lin, Keng-Chang Tsai, Wei-Chun HuangFu, Yu-Ching Lee

A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker

一种用于指导卵巢癌治疗和识别有效生物标志物的弱监督深度学习方法

Ching-Wei Wang, Yu-Ching Lee, Cheng-Chang Chang, Yi-Jia Lin, Yi-An Liou, Po-Chao Hsu, Chun-Chieh Chang, Aung-Kyaw-Oo Sai, Chih-Hung Wang, Tai-Kuang Chao

EGFL6 promotes colorectal cancer cell growth and mobility and the anti-cancer property of anti-EGFL6 antibody

EGFL6促进结直肠癌细胞生长和迁移以及抗EGFL6抗体的抗癌特性

Ting-Yi Sung #, Han-Li Huang #, Chun-Chun Cheng, Fu-Ling Chang, Po-Li Wei, Ya-Wen Cheng, Cheng-Chiao Huang, Yu-Ching Lee, Wei-Chun HuangFu, Shiow-Lin Pan